ÂÜÀòÂÒÂ×

David Vogan is an accomplished scientist with extensive experience in assay development and next-generation sequencing (NGS) across multiple roles in the biotechnology field. At Adaptive Biotechnologies Corp. since September 2019, David has progressed through various scientific positions, contributing to advanced research initiatives. Prior to this, at Scisco Genetics Inc. from July 2015 to September 2019, David served as Lead Scientist in assay development, where responsibilities included designing and optimizing NGS methods, performing genotyping for immunogenetic loci, and ensuring compliance with regulatory standards. David's earlier roles at Fred Hutch and GENEWIZ provided foundational skills in clinical research and sequencing services. David holds a degree in Plant Science with a focus on Biotechnology from Washington State University.